Thorsten Cramer

10.7k total citations · 5 hit papers
78 papers, 8.2k citations indexed

About

Thorsten Cramer is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Thorsten Cramer has authored 78 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 37 papers in Cancer Research and 11 papers in Surgery. Recurrent topics in Thorsten Cramer's work include Cancer, Hypoxia, and Metabolism (33 papers), Angiogenesis and VEGF in Cancer (10 papers) and RNA modifications and cancer (7 papers). Thorsten Cramer is often cited by papers focused on Cancer, Hypoxia, and Metabolism (33 papers), Angiogenesis and VEGF in Cancer (10 papers) and RNA modifications and cancer (7 papers). Thorsten Cramer collaborates with scholars based in Germany, Netherlands and United States. Thorsten Cramer's co-authors include Randall S. Johnson, Nadine Rohwer, Victor Nizet, Bertram Wiedenmann, Carole Peyssonnaux, David Pfander, Gary S. Firestein, Hans-Peter Gerber, Volker H. Haase and Irmgard Förster and has published in prestigious journals such as Science, Cell and Journal of Biological Chemistry.

In The Last Decade

Thorsten Cramer

76 papers receiving 8.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation

2003 1.6k citations Thorsten Cramer, Yuji Yamanishi et al. Cell profile →
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway

2014 1.1k citations Thorsten Cramer et al. profile →
Hypoxia-induced neutrophil survival is mediated by HIF-1α–dependent NF-κB activity

2005 709 citations Randall S. Johnson, Thorsten Cramer et al. profile →
HIF-1α expression regulates the bactericidal capacity of phagocytes

2005 566 citations Thorsten Cramer, Victor Nizet et al. Journal of Clinical Investigation profile →
Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways

2011 510 citations Nadine Rohwer, Thorsten Cramer Drug Resistance Updates profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Thorsten Cramer	3.7k	2.8k	1.8k	1.1k	789	78	8.2k
Anton Jan van Zonneveld	5.0k 1.3×	3.1k 1.1×	1.1k 0.6×	874 0.8×	1.3k 1.6×	211	10.6k
Tucker Collins	3.9k 1.1×	1.6k 0.6×	2.0k 1.1×	977 0.9×	1.0k 1.3×	43	8.2k
Thomas Kislinger	5.8k 1.6×	1.5k 0.5×	1.3k 0.7×	851 0.7×	662 0.8×	168	11.7k
Mary E. Gerritsen	4.1k 1.1×	1.6k 0.6×	1.9k 1.1×	1.2k 1.1×	750 1.0×	122	8.5k
Paul J. Higgins	4.0k 1.1×	1.5k 0.5×	1.1k 0.6×	1.2k 1.0×	835 1.1×	226	8.5k
Matthias Clauss	4.8k 1.3×	1.5k 0.5×	2.4k 1.3×	1.1k 1.0×	971 1.2×	107	9.3k
Jin Zhang	4.7k 1.3×	1.5k 0.5×	1.4k 0.8×	1.5k 1.3×	503 0.6×	232	8.5k
Yasuyuki Sasaguri	2.9k 0.8×	1.6k 0.6×	1.4k 0.8×	1.4k 1.2×	1.3k 1.6×	238	8.0k
Vinay Tergaonkar	6.4k 1.7×	3.3k 1.2×	2.5k 1.4×	1.9k 1.6×	498 0.6×	122	10.5k
David K. Ann	5.0k 1.3×	2.0k 0.7×	873 0.5×	1.9k 1.6×	507 0.6×	171	8.3k

Countries citing papers authored by Thorsten Cramer

Since Specialization

Citations

This map shows the geographic impact of Thorsten Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thorsten Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thorsten Cramer more than expected).

Fields of papers citing papers by Thorsten Cramer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thorsten Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thorsten Cramer. The network helps show where Thorsten Cramer may publish in the future.

Co-authorship network of co-authors of Thorsten Cramer

This figure shows the co-authorship network connecting the top 25 collaborators of Thorsten Cramer. A scholar is included among the top collaborators of Thorsten Cramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thorsten Cramer. Thorsten Cramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Bibra, Helene von, et al.. (2024). Kommentar zu den neuen „Lebensmittelbezogenen Ernährungsempfehlungen für Deutschland“ der Deutschen Gesellschaft für Ernährung (DGE). Aktuelle Ernährungsmedizin. 50(3). 168–174. 1 indexed citations

2.

Cramer, Thorsten, et al.. (2024). Why Do Cancer Patients Die?. SHILAP Revista de lepidopterología. 7(2). 80–81. 1 indexed citations

3.

Lu, Xinjun, Shanshan Deng, Benjamin L. Green, et al.. (2023). Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models. Journal of Clinical Investigation. 133(11). 27 indexed citations

4.

Kroh, Andreas, Athanassios Fragoulis, Diana Möckel, et al.. (2023). Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC. Neoplasia. 46. 100945–100945. 3 indexed citations

5.

Cramer, Thorsten. (2023). Impact of dietary carbohydrate restriction on the pathobiology of Hepatocellular Carcinoma: The gut-liver axis and beyond. Seminars in Immunology. 66. 101736–101736. 4 indexed citations

6.

Cramer, Thorsten, et al.. (2023). Plasma erythritol and cardiovascular risk: is there evidence for an association with dietary intake?. Frontiers in Nutrition. 10. 1195521–1195521.

7.

Dupont, Aline, Kaiyi Zhang, Christian H. Holland, et al.. (2022). Stabilization but No Functional Influence of HIF-1α Expression in the Intestinal Epithelium during Salmonella Typhimurium Infection. Infection and Immunity. 90(2). e0022221–e0022221. 7 indexed citations

8.

Cramer, Thorsten & Peter Vaupel. (2022). Severe hypoxia is a typical characteristic of human hepatocellular carcinoma: Scientific fact or fallacy?. Journal of Hepatology. 76(4). 975–980. 30 indexed citations

9.

Eickhoff, Roman, Andreas Kroh, Hans Duimel, et al.. (2021). Deletion of mTOR in liver epithelial cells enhances hepatic metastasis of colon cancer. The Journal of Pathology. 255(3). 270–284. 4 indexed citations

10.

Eduati, Federica, Patricia Jaaks, Thorsten Cramer, et al.. (2020). Patient‐specific logic models of signaling pathways from screenings on cancer biopsies to prioritize personalized combination therapies. Molecular Systems Biology. 16(6). 24 indexed citations

11.

Cramer, Thorsten, et al.. (2020). Barrier integrity and chronic inflammation mediated by HIF-1 impact on intestinal tumorigenesis. Cancer Letters. 490. 186–192. 26 indexed citations

12.

Eduati, Federica, Patricia Jaaks, Thorsten Cramer, et al.. (2020). Patient‐specific logic models of signaling pathways from screenings on cancer biopsies to prioritize personalized combination therapies. Molecular Systems Biology. 16(2). e8664–e8664. 48 indexed citations

13.

Fabris, Luca, María J. Perugorria, Joachim C. Mertens, et al.. (2019). The tumour microenvironment and immune milieu of cholangiocarcinoma. Liver International. 39(S1). 63–78. 122 indexed citations

14.

Möckel, Diana, Athanassios Fragoulis, Jochen Springer, et al.. (2019). Macrophages protect against loss of adipose tissue during cancer cachexia. Journal of Cachexia Sarcopenia and Muscle. 10(5). 1128–1142. 37 indexed citations

15.

Eduati, Federica, Ramesh Utharala, Dharanija Madhavan, et al.. (2018). A microfluidics platform for combinatorial drug screening on cancer biopsies. Nature Communications. 9(1). 2434–2434. 188 indexed citations

16.

Rohwer, Nadine & Thorsten Cramer. (2011). Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways. Drug Resistance Updates. 14(3). 191–201. 510 indexed citations breakdown →

17.

Rohwer, Nadine, Martina Welzel, David Pfander, et al.. (2008). Hypoxia-Inducible Factor 1α Mediates Anoikis Resistance via Suppression of α5 Integrin. Cancer Research. 68(24). 10113–10120. 87 indexed citations

18.

Cramer, Thorsten, Ernestina Schipani, Randall S. Johnson, B. Swoboda, & David Pfander. (2004). Expression of VEGF isoforms by epiphyseal chondrocytes during low-oxygen tension is HIF-1α dependent. Osteoarthritis and Cartilage. 12(6). 433–439. 64 indexed citations

19.

Cramer, Thorsten, Yuji Yamanishi, Björn E. Clausen, et al.. (2003). HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation. Cell. 112(5). 645–657. 1641 indexed citations breakdown →

20.

Cramer, Thorsten. (1963). ANTI-SCHOOLCHILD-SMOKING CAMPAGIN IN DENMARK.. PubMed. 19. 935–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact